Video - Traumatic Brain Injury and Alzheimer's Disease: Exploring the Pathological Overlap and Risk of Neurodegeneration

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: Ioannis Mavroudis, Foivos Petridis, Dimitrios Kazis, Cătălina IonescuAlexandru Ioan Cuza University of Iași Apollonia University, Bogdan Novac, Antoneta Dacia Petroaie, Otilia Novac, Irina Luciana Gurzu, Bogdan Gurzu
Format: Recurso digital
Published: Zenodo 2025
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866902265544048640
author Ioannis Mavroudis
Foivos Petridis
Dimitrios Kazis
Cătălina IonescuAlexandru Ioan Cuza University of Iași Apollonia University
Bogdan Novac
Antoneta Dacia Petroaie
Otilia Novac
Irina Luciana Gurzu
Bogdan Gurzu
author_facet Ioannis Mavroudis
Foivos Petridis
Dimitrios Kazis
Cătălina IonescuAlexandru Ioan Cuza University of Iași Apollonia University
Bogdan Novac
Antoneta Dacia Petroaie
Otilia Novac
Irina Luciana Gurzu
Bogdan Gurzu
contents <p>Traumatic brain injury (TBI), particularly repetitive mild TBI, has emerged as a significant risk factor for the development of Alzheimer’s disease (AD)-like pathology. Neuropathological studies have identified shared features between TBI and AD, such as amyloid-beta (Aβ) deposition and hyperphosphorylated tau (p-tau) aggregates. However, distinct regional patterns differentiate chronic traumatic encephalopathy (CTE) from AD, making the relationship between TBI and neurodegenerative diseases a complex and debated issue. Diagnostic challenges are compounded by overlapping clinical symptoms and the limitations of current imaging and biomarker techniques, which hinder precise differentiation between TBI-associated neurodegeneration and classical AD. Despite these challenges, recent advances in tau-specific imaging technologies and blood-based biomarkers hold promise for enhancing diagnostic accuracy and distinguishing TBI-related changes from AD pathology. This study aims to enhance the understanding of the mechanisms linking TBI and AD by examining shared and distinct pathological features. It explores how TBI may trigger or accelerate neurodegenerative processes leading to AD-like pathology. By focusing on amyloid-beta and tau patterns in TBI, we aim to clarify the role of TBI in AD development and identify potential biomarkers for early detection and intervention. The study also emphasizes the need for longitudinal research and personalized therapeutic strategies to mitigate TBI's long-term effects on brain health.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_16141049
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle Video - Traumatic Brain Injury and Alzheimer's Disease: Exploring the Pathological Overlap and Risk of Neurodegeneration
Ioannis Mavroudis
Foivos Petridis
Dimitrios Kazis
Cătălina IonescuAlexandru Ioan Cuza University of Iași Apollonia University
Bogdan Novac
Antoneta Dacia Petroaie
Otilia Novac
Irina Luciana Gurzu
Bogdan Gurzu
<p>Traumatic brain injury (TBI), particularly repetitive mild TBI, has emerged as a significant risk factor for the development of Alzheimer’s disease (AD)-like pathology. Neuropathological studies have identified shared features between TBI and AD, such as amyloid-beta (Aβ) deposition and hyperphosphorylated tau (p-tau) aggregates. However, distinct regional patterns differentiate chronic traumatic encephalopathy (CTE) from AD, making the relationship between TBI and neurodegenerative diseases a complex and debated issue. Diagnostic challenges are compounded by overlapping clinical symptoms and the limitations of current imaging and biomarker techniques, which hinder precise differentiation between TBI-associated neurodegeneration and classical AD. Despite these challenges, recent advances in tau-specific imaging technologies and blood-based biomarkers hold promise for enhancing diagnostic accuracy and distinguishing TBI-related changes from AD pathology. This study aims to enhance the understanding of the mechanisms linking TBI and AD by examining shared and distinct pathological features. It explores how TBI may trigger or accelerate neurodegenerative processes leading to AD-like pathology. By focusing on amyloid-beta and tau patterns in TBI, we aim to clarify the role of TBI in AD development and identify potential biomarkers for early detection and intervention. The study also emphasizes the need for longitudinal research and personalized therapeutic strategies to mitigate TBI's long-term effects on brain health.</p>
title Video - Traumatic Brain Injury and Alzheimer's Disease: Exploring the Pathological Overlap and Risk of Neurodegeneration
url https://doi.org/10.5281/zenodo.16141049